. Author manuscript; available in PMC: 2018 Apr 1.

Published in final edited form as: Am J Prev Med. 2016 Dec 6;52(4):459–468. doi: 10.1016/j.amepre.2016.10.013

Table 3.

CVD Incidence in Subset With Additional Baseline Risk Factor Data, VA 2005-2012^a

Characteristic	Total CVD		Coronary artery disease		Cerebrovascular disease		Peripheral vascular disease		Heart failure
	HR	95% CI	HR	95% CI	HR	95% CI	HR	95% CI	HR	95% CI
MOVE! participation	0.87	0.83-0.91	0.86	0.81-0.91	0.91	0.85-0.98	0.94	0.87-1.01	0.83	0.77-0.89
Systolic BP, 10mm Hg	1.05	1.04-1.05	1.03	1.03-1.04	1.07	1.06-1.08	1.07	1.06-1.08	1.08	1.07-1.09
HDL cholesterol, 10mg/dL	0.94	0.93-0.95	0.92	0.91-0.93	0.96	0.94-0.97	0.94	0.92-0.96	1.01	0.99-1.02
Non-HDL cholesterol, 10mg/dL	1.01	1.01-1.01	1.02	1.01-1.02	1.01	1.01-1.02	1.01	1.01-1.02	0.99	0.99-1.00
Random plasma glucose, 10mg/dL	1.01	1.01-1.01	1.01	1.01-1.01	1.01	1.01-1.01	1.02	1.01-1.02	1.02	1.02-1.03

Multivariable models identical to Table 2 above, but including additional adjustment for systolic blood pressure, HDL cholesterol, non-HDL cholesterol, and random plasma glucose, and restricted to patients with available data for these laboratory and clinical measures (N=701,930). Hazard ratios for clinical measures are per 10-unit increase.

CVD, cardiovascular disease; VA, Veterans Health Administration; HR, hazard ratio; HDL